These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 29456202)

  • 1. Contrast-induced nephropathy: Pathophysiology, risk factors, and prevention.
    Hossain MA; Costanzo E; Cosentino J; Patel C; Qaisar H; Singh V; Khan T; Cheng JS; Asif A; Vachharajani TJ
    Saudi J Kidney Dis Transpl; 2018; 29(1):1-9. PubMed ID: 29456202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-induced nephropathy: Basic concepts, pathophysiological implications and prevention strategies.
    Mamoulakis C; Tsarouhas K; Fragkiadoulaki I; Heretis I; Wilks MF; Spandidos DA; Tsitsimpikou C; Tsatsakis A
    Pharmacol Ther; 2017 Dec; 180():99-112. PubMed ID: 28642116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remote Ischemic Preconditioning To Reduce Contrast-Induced Nephropathy: A Randomized Controlled Trial.
    Menting TP; Sterenborg TB; de Waal Y; Donders R; Wever KE; Lemson MS; van der Vliet JA; Wetzels JF; SchultzeKool LJ; Warlé MC
    Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):527-32. PubMed ID: 26015372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous Fluid Therapy Is Associated with a Reduced Incidence of Contrast-Induced Nephropathy but not with a Reduced Long-Term Incidence of Renal Dysfunction After Cardiac Catheterization.
    Bottinor W; Chawla R; Danyi P; Patel K; Turlington J; Sangal K; Hong W; Perera RA; Jovin IS
    Cardiovasc Revasc Med; 2020 Jan; 21(1):20-23. PubMed ID: 31378387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevention of contrast-induced nephropathy.
    Au TH; Bruckner A; Mohiuddin SM; Hilleman DE
    Ann Pharmacother; 2014 Oct; 48(10):1332-42. PubMed ID: 24994723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease.
    Sigterman TA; Krasznai AG; Snoeijs MG; Heijboer R; Schurink GW; Bouwman LH
    Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):386-93. PubMed ID: 26460289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of radiocontrast-induced nephropathy.
    Asif A; Epstein M
    Am J Kidney Dis; 2004 Jul; 44(1):12-24. PubMed ID: 15211433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
    Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
    Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Effects and Clinical Investigations for Contrast-Induced Nephropathy After Coronary Angiography or Percutaneous Coronary Intervention in Patients With Diabetes.
    Zhang MM; Lv QZ; Li XY
    Am J Ther; 2017; 24(4):e423-e430. PubMed ID: 26308327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies.
    Azzalini L; Spagnoli V; Ly HQ
    Can J Cardiol; 2016 Feb; 32(2):247-55. PubMed ID: 26277092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
    Boccalandro F; Amhad M; Smalling RW; Sdringola S
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients.
    Osugi N; Suzuki S; Shibata Y; Tatami Y; Harata S; Ota T; Hayashi M; Yasuda Y; Ishii H; Shimizu A; Murohara T
    Clin Exp Nephrol; 2017 Jun; 21(3):391-397. PubMed ID: 27339445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of allopurinol pretreatment for prevention of contrast-induced nephropathy: a randomized controlled trial.
    Erol T; Tekin A; Katırcıbaşı MT; Sezgin N; Bilgi M; Tekin G; Zümrütdal A; Sezgin AT; Müderrisoğlu H
    Int J Cardiol; 2013 Aug; 167(4):1396-9. PubMed ID: 22572633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
    Garcia S; Ko B; Adabag S
    Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of contrast-induced nephropathy in kidney transplant recipients.
    Haider M; Yessayan L; Venkat KK; Goggins M; Patel A; Karthikeyan V
    Transplant Proc; 2015 Mar; 47(2):379-83. PubMed ID: 25769577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study.
    An JN; Yoo KD; Hwang JH; Kim HL; Kim SH; Yang SH; Kim JH; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
    Nephrology (Carlton); 2015 Aug; 20(8):552-9. PubMed ID: 25783484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-induced nephropathy.
    Marenzi G; Cabiati A; Milazzo V; Rubino M
    Intern Emerg Med; 2012 Oct; 7 Suppl 3():S181-3. PubMed ID: 23073854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-induced nephropathy in percutaneous coronary interventions: pathogenesis, risk factors, outcome, prevention and treatment.
    Aurelio A; Durante A
    Cardiology; 2014; 128(1):62-72. PubMed ID: 24557146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.